The first study to functionally assess three MRAP2 variants identified in children with extreme obesity, showed only one variant affected MC4R-generated cAMP responses [25], although only a single concentration (1 μM) of αMSH was used in an endpoint assay (AlphaScreen). The gene discussed is MRAP2; the disease is obesity due to melanocortin 4 receptor deficiency.